Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Aelix Therapeutics

Aelix Therapeutics
2015 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$13M LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of a new therapeutic vaccine designed to help people with HIV. The company's new therapeutic vaccine is basedon a disruptive design of a T-cellimmunogen that is able to elicit a strong broad and focused responseagainst HIV and has the potential to radically transform the treatment of HIV infection, enabling patients to get cured from HIV diseases.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Delivery
Primary Office
  • Parc Científic de Barcelona
  • Carrer Baldiri i Reixac 4-8
  • 08028 Barcelona
  • Spain

+34 934 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Aelix Therapeutics’s full profile, request a free trial.

Aelix Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 11-Jan-2016 $13M 0000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Aelix Therapeutics Competitors (17)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Viralytics Corporate Backed or Acquired Australia 0 000.00 000000&0 000.00
000000 Venture Capital-Backed San Diego, CA 0 00.000 0000000000 0 00.000
00000000 Venture Capital-Backed Sunnyvale, CA 00 00.000 0000000000 00.000
0000000 Venture Capital-Backed Farmington, CT 00 00.000 000000000 00.000
0000 0000000 Venture Capital-Backed Santa Ana, CA 000.00 00000000000 000.00
To view this company’s complete list of competitors, request access »

Aelix Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Caixa Capital Risc Corporate Venture Capital Minority 000 0000 000000 0
Johnson & Johnson Innovation - JJDC Corporate Venture Capital Minority 000 0000 000000 0
Ysios Capital Venture Capital Minority 000 0000 000000 0

Aelix Therapeutics Executive Team (7)

Name Title Board
Seat
Contact
Info
José Luis Cabero Chief Executive Officer
Christian Brander Ph.D Chief Scientific Officer & Co-Founder
Jordi Naval Co-Founder & Board Member
Bonaventura Clotet Ph.D Co-Founder, Board Member & Member of Scientific Advisory Board
Lance Berman Chief Medical Officer

2 Former Executives

You’re viewing 5 of 7 executives. Get the full list »

Aelix Therapeutics Board Members (6)

Name Representing Role Since Contact
Info
Bonaventura Clotet Ph.D Aelix Therapeutics Co-Founder, Board Member & Member of Scientific Advisory Board 000 0000
Jeanne Bolger MD Johnson & Johnson Innovation - JJDC Board Member 000 0000
Jordi Naval Aelix Therapeutics Co-Founder & Board Member 000 0000
José Antonio Mesa Caixa Capital Risc Board Member 000 0000
Karen Wagner Ysios Capital Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »